A contraction stress model of hypertrophic cardiomyopathy due to thick filament sarcomere mutations
R. Cohn, K. Thakar, A. Lowe, F. Ladha, A. Pettinato, E. Meredith, Y.-s. Chen, K. Atamanuk, B. Huey, J. T. Hinson
This study uses CRISPR/Cas9 to create HCM iPSc models and finds that mutations cause hypercontractility and p53 activation linked to oxidative stress, suggesting p53 as a therapeutic target.
bioRxiv · Sep 4, 2018Cell Biology